According to Gram Research analysis, vitamins have contradictory effects on cancer risk—some show genuine anti-cancer potential in specific situations, while others increase cancer risk when taken in high doses. A 2026 comprehensive review found that vitamin K2 triggers leukemia cell death, vitamin D enhances anti-tumor immunity, and high-dose vitamin C kills certain colorectal cancer cells, but beta-carotene increases lung cancer risk in smokers, vitamin E raises prostate cancer risk, and antioxidant supplements may interfere with chemotherapy. The key finding: routine vitamin supplementation lacks evidence, while correcting documented deficiencies remains important, and all supplement decisions should be individualized with medical guidance.
A major review of decades of research reveals that vitamins have complicated effects on cancer—some show real promise in fighting tumors, while others may actually increase cancer risk depending on the dose and type. Researchers found that vitamin K2 can trigger cancer cell death, vitamin D boosts immune defenses, and high-dose vitamin C may kill certain cancer cells. However, the review also warns that too much beta-carotene increases lung cancer risk in smokers, excess vitamin E raises prostate cancer risk, and antioxidant supplements might interfere with chemotherapy. The key finding: there’s no one-size-fits-all vitamin strategy for cancer prevention or treatment—what helps one person might harm another.
Key Statistics
A 2026 systematic review of vitamin and cancer research found that beta-carotene supplements increase lung cancer risk in smokers, while vitamin E supplements raise prostate cancer risk in men, demonstrating that high-dose supplementation can be harmful rather than protective.
According to a 2026 comprehensive review, vitamin K2 triggers autophagy-driven leukemia cell death, pharmacologic vitamin C selectively kills KRAS- and BRAF-mutated colorectal cancer cells, and vitamin D enhances microbiome-dependent antitumor immunity, showing context-specific anti-cancer mechanisms.
A 2026 review identified U-shaped dose-response patterns for vitamins and cancer risk, meaning both deficiency and excess increase risk, with an optimal middle range—explaining why simple ’take more vitamins’ advice fails.
Research shows that antioxidant supplementation during chemotherapy and radiotherapy may weaken the oxidative stress mechanisms essential for cancer cell death, potentially reducing treatment effectiveness.
The Quick Take
- What they studied: Whether vitamins prevent cancer, help treat it, or potentially make it worse—examining six major vitamins (A, D, E, K, C, and B-complex) across prevention, treatment response, and side effects.
- Who participated: This was a review of hundreds of previous studies, including lab experiments, population studies following thousands of people, and clinical trials with cancer patients. No single group of participants—instead, researchers analyzed all existing evidence.
- Key finding: Vitamins have contradictory effects: some show strong anti-cancer properties in specific situations (like vitamin K2 killing leukemia cells), while others increase cancer risk when taken in high doses (beta-carotene in smokers, vitamin E in men). The relationship between vitamin dose and cancer risk often follows a U-shape—too little is bad, too much is bad, but the right amount might be beneficial.
- What it means for you: Taking random vitamin supplements ‘just in case’ isn’t supported by evidence and could be harmful. If you have a real vitamin deficiency, correcting it matters. If you have cancer or are at high risk, talk to your doctor before taking any supplements—the same vitamin that helps one person might interfere with another person’s treatment.
The Research Details
This was a scoping review, which means researchers systematically searched through decades of published studies about vitamins and cancer. They looked at three types of evidence: laboratory studies showing how vitamins affect cancer cells, population studies following thousands of people over years to see who got cancer, and clinical trials testing vitamins in cancer patients. The researchers followed strict guidelines (called PRISMA-ScR) to make sure they found and evaluated studies fairly and consistently.
They focused on six vitamins that have the most research: vitamins A, D, E, K, C, and the B-complex group. For each vitamin, they examined whether it prevented cancer, affected how well cancer treatments worked, or caused side effects. This approach let them see the full picture—both the promising findings and the concerning ones—rather than cherry-picking studies that supported one conclusion.
A scoping review is the right tool for a complicated topic like this because vitamins affect cancer in many different ways depending on the dose, the type of cancer, and the individual person. By reviewing all available evidence rather than just a few studies, researchers can identify patterns and contradictions. This helps doctors and patients understand that vitamins aren’t simply ‘good’ or ‘bad’—their effects depend on context.
This review synthesized evidence from multiple study types (lab research, population studies, and clinical trials), which strengthens the conclusions. However, the review itself didn’t conduct new experiments or analyze raw data—it summarized what others found. The quality of conclusions depends on the quality of the original studies reviewed. Some findings are based on strong evidence (like vitamin E and prostate cancer risk), while others are based on smaller or preliminary studies. The authors appropriately note that many findings need more research before doctors can confidently recommend them.
What the Results Show
The review identified several vitamins with genuine anti-cancer potential in specific situations. Vitamin K2 appears to trigger a form of cell death in leukemia cells through a process called autophagy. Vitamin D enhances the immune system’s ability to fight tumors, particularly when the gut microbiome is healthy. High-dose intravenous vitamin C (given by IV, not pills) selectively kills colorectal cancer cells that have specific genetic mutations (KRAS and BRAF). Niacin (a B vitamin) can reshape the immune environment around tumors in ways that might help the body fight cancer.
However, the review also documented clear harms. Beta-carotene supplements increase lung cancer risk in smokers—this finding comes from multiple large studies. Vitamin E supplements raise the risk of prostate cancer in men. Antioxidant supplements (including vitamins C and E) may actually protect cancer cells from chemotherapy and radiation by reducing the oxidative stress that kills tumor cells. This is a critical concern: the same antioxidant effect that sounds protective might interfere with cancer treatment.
A striking pattern emerged: the relationship between vitamin dose and cancer risk is often U-shaped. This means both too little and too much increase risk, with an optimal middle range. This explains why simple advice like ’take more vitamins’ fails—you need the right amount, not just any amount.
The review found that vitamin D repletion (correcting deficiency) during immunotherapy shows promise but remains unproven in large trials. Vitamin-targeted nanoparticles—a new technology delivering vitamins directly to cancer cells—are emerging as a potential strategy but are still experimental. The timing of supplementation matters: taking antioxidants during chemotherapy might reduce treatment effectiveness, while correcting deficiencies before treatment might improve outcomes. Individual genetic differences affect how people respond to vitamins, suggesting that personalized approaches will be necessary.
This review updates and expands on decades of conflicting vitamin research. Previous studies often reached opposite conclusions because they focused on different populations, doses, or cancer types. For example, some older studies suggested vitamin E was protective, while newer research shows it increases prostate cancer risk. This review explains why: the dose matters enormously, and the effect depends on the specific cancer type and individual characteristics. The finding that antioxidants might interfere with chemotherapy is relatively recent and represents a major shift in how oncologists think about supplements during treatment.
This review synthesized existing studies rather than conducting new research, so conclusions are only as strong as the original studies. Some vitamins have extensive research (like vitamin D), while others have limited evidence. Many studies were conducted in lab settings or animals, which don’t always translate to humans. The review couldn’t account for differences in how people absorb vitamins, genetic variations that affect vitamin metabolism, or interactions between multiple supplements. Most importantly, the review notes that ‘context-dependent’ effects mean findings from one population (like smokers) may not apply to others. Larger, well-designed clinical trials are needed before doctors can confidently recommend specific vitamin strategies for cancer prevention or treatment.
The Bottom Line
For cancer prevention in generally healthy people: Focus on getting vitamins from food rather than supplements. Correct any documented deficiencies with your doctor’s guidance. Avoid high-dose supplements of beta-carotene (especially if you smoke), vitamin E, and antioxidant combinations without medical supervision. For people with cancer or undergoing treatment: Do not start any supplements without discussing with your oncologist, as some may interfere with chemotherapy or radiation. If you have a vitamin deficiency, correcting it may improve treatment tolerance and outcomes. High-dose intravenous vitamin C and vitamin D repletion during immunotherapy show promise but should only be pursued through clinical trials or under specialist supervision. Confidence level: Moderate for harms (beta-carotene, vitamin E), Low to Moderate for benefits (most therapeutic applications).
Cancer patients and survivors should absolutely care about this research—supplements could affect treatment effectiveness or side effects. People at high risk for cancer (family history, smoking, genetic predisposition) should understand that routine supplementation isn’t protective and may be harmful. Smokers should specifically avoid beta-carotene supplements. Men should be cautious about high-dose vitamin E. People with documented vitamin deficiencies benefit from correction. Healthy people without deficiencies likely don’t need supplementation based on this evidence. Healthcare providers treating cancer patients need this information to counsel patients about supplement safety.
If you correct a real vitamin deficiency, you might notice improved energy and general health within weeks to months. If you’re taking vitamins to prevent cancer, understand that cancer develops over years or decades—you won’t see immediate results. For people undergoing cancer treatment, the effects of supplements (both helpful and harmful) could be noticeable within the timeframe of treatment (weeks to months). The anti-cancer effects of vitamins shown in lab studies typically take months to years to manifest in human populations, which is why large clinical trials are necessary.
Frequently Asked Questions
Should I take vitamin supplements to prevent cancer?
Routine supplementation for cancer prevention lacks scientific support and may be harmful. A 2026 review found that high-dose beta-carotene increases lung cancer risk in smokers and vitamin E raises prostate cancer risk. Focus on getting vitamins from food and correct documented deficiencies with medical guidance.
Is vitamin D good for cancer prevention?
Vitamin D shows promise for cancer prevention and treatment by enhancing immune function, particularly through the gut microbiome. However, the evidence is still developing. If you have low vitamin D, correcting it may help, but routine high-dose supplementation without testing isn’t recommended.
Can I take supplements while undergoing cancer treatment?
Do not start supplements without consulting your oncologist. Some supplements, particularly antioxidants like vitamins C and E, may interfere with chemotherapy and radiation by protecting cancer cells from the oxidative stress that kills them. Always discuss any supplements with your cancer care team.
What vitamins are most dangerous for cancer risk?
Beta-carotene supplements increase lung cancer risk in smokers, and vitamin E supplements raise prostate cancer risk in men. Antioxidant supplements may also interfere with cancer treatment effectiveness. Avoid high-dose supplements of these vitamins without medical supervision.
Can high-dose vitamin C treat cancer?
High-dose intravenous vitamin C shows promise in lab studies for killing specific colorectal cancer cells with KRAS and BRAF mutations, but this remains unproven in large human trials. It should only be pursued through clinical trials or under specialist supervision, not as self-treatment.
Want to Apply This Research?
- Track daily vitamin intake (type, dose, form) alongside any cancer screening results, treatment side effects, or energy levels. Note whether vitamins are from food sources or supplements. If undergoing cancer treatment, track supplement use and discuss with your oncology team at each visit.
- Instead of adding random supplements, use the app to identify potential deficiencies by logging your diet for a week and comparing to recommended intake levels. If deficiencies appear, discuss with your doctor before supplementing. For cancer patients, use the app to maintain a supplement log to share with your medical team, ensuring no harmful interactions with treatment.
- Quarterly review: Check whether you’re still taking supplements that lack evidence (and discuss discontinuation with your doctor). Annual assessment: Have your doctor check vitamin D, B12, and other levels through blood tests rather than guessing. For cancer patients: Update your supplement list at every oncology appointment. Track any side effects or changes in treatment tolerance that might relate to supplements.
This article summarizes research findings and is not medical advice. Vitamins and supplements can have serious interactions with cancer treatments and may affect cancer risk in ways that depend on individual factors. Anyone with cancer, at high risk for cancer, or considering vitamin supplementation should consult with their oncologist or healthcare provider before starting, stopping, or changing any supplements. Do not use this information to replace professional medical guidance. The effects of vitamins on cancer are complex and highly individual—what helps one person may harm another.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.